Download PDF
1 / Pages

Other users also viewed these articles

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;
Clin Investig Arterioscler. 2023;35:263-71
Clinical profile of severe hypercholesterolemia in 156,000 adults in primary care Teresa Gijón-Conde; Carolina Ferré Sánchez; Isabel Ibáñez Delgado; Berenice Rodríguez Jiménez; José R. Banegas;
Clin Investig Arterioscler. 2024;36:1-11
Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023 Pablo Pérez-Martínez; Emilio Ros; Juan Pedro-Botet; Fernando Civeira; Vicente Pascual; Carmen Garcés; Rosa Solá; Francisco Pérez-Jiménez; José M. Mostaza;
Clin Investig Arterioscler. 2023;35:248-61